
Clinical
Latest News
Advertisement
CME Content
Advertisement



Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact's work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.


Korean drug maker Celltrion Healthcare recently presented new findings from a 2-part study at the Annual European Congress of Rheumatology 2019 meeting about subcutaneous biosimilar CT-P13 (Inflectra, Remsima).
Advertisement
Advertisement
Trending on AJMC
1
Physical Activity, Vaccination May Protect Against Long COVID
2
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
3
Novel Machine Learning Model Improves MASLD Detection in Type 2 Diabetes
4
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
5